Insilico Medicine Unveils AI Assistant for Medical Research Drafting
On a press webinar today, Insilico Medicine, known for its advancements in AI-driven drug discovery, has announced updates to its …
All Posts
Touchlight and GSK Partner for Enzymatic dbDNA Production in mRNA Manufacturing
Touchlight, a contract development and manufacturing organization (CDMO) specializing in enzymatic DNA production, has entered into a licensing agreement with …
The Synergistic Potential of AI and Synthetic Biology: Interview with S&P Global’s Miriam Fernández
The rapid convergence of artificial intelligence (AI) and synthetic biology (synbio) is set to revolutionize a multitude of industries, ranging …
Abiologics Emerges to Introduce New Class of Biologic Drugs
Flagship Pioneering, a bioplatform innovation company, has announced the launch of Abiologics, a new venture focused on revolutionizing the field …
Proscia Introduces Enhanced Concentriq AP with Multi-AI Workflows for Pathology
Proscia, a provider of AI-powered pathology solutions for precision medicine, has announced an update to its Concentriq AP platform. The …
New Insurance Model Could Transform Clinical Trial Financing
A novel initiative by Medical and Commercial International Limited (MCI) and GATC Health Corp, supported by Lloyd's of London, promises …
Biotech Trends to Watch: Reflecting on the First Half of 2024
If we talk about tech advances in pharma and biotech, the year 2024 has been a blast so far! Last …
New Liquid Biopsy Method Enables Monitoring of Disease Evolution in Metastatic Prostate Cancer Patients
A new liquid biopsy approach enables monitoring of disease evolution in patients with metastatic prostate cancer through the analysis of …
10 Notable Biotech Companies With Recent Major VC Rounds
As the biotech sector recovers to pre-COVID investment levels, venture capital firms have become more selective in their funding choices. …
Accidental Breakthrough in Aging Research
Recent research reveals that blocking an inflammation-promoting protein, IL-11, can significantly extend the lifespan and improve the health of laboratory …
Artiva Biotherapeutics Lowers IPO Price, Raises $167 Million for Autoimmune Therapies
Artiva Biotherapeutics, a clinical-stage biotechnology company, has raised $167 million through its initial public offering (IPO). The company offered 13.9 …
SkyCell and Validaide Team Up to Reduce Carbon Emissions in Pharmaceutical Supply Chains
SkyCell, a technology company specializing in the pharmaceutical supply chain, has partnered with Validaide, a lane risk assessment platform, to …